Sarah Chandler
Gerontology · Ontario, ORNPI 1720144793
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 54.3% of the total. Reporting peaked in 2022 at $483 and has fallen 86.6% since, to $65 in 2025.
Across 35 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$334
- Grifols USA, LLC$57
- Novo Nordisk$40
- Lilly USA, LLC$38
- Teva Pharmaceuticals USA, Inc.$32
- AstraZeneca$32
- plus $83 from 5 others
What the payments were for
- Food & beverage$616100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 19 | $334 |
| Grifols USA, LLC | 3 | $57 |
| Novo Nordisk | 2 | $40 |
| Lilly USA, LLC | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| AstraZeneca | 2 | $32 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Indivior Inc. | 1 | $19 |
| Viatris Specialty LLC | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
How this compares
$616 in reported general payments places this provider in the 70th percentile of 53 gerontology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 111 | $68,546 |
| FycompaPerampanel | 16 | $20,800 |
| JardianceEmpagliflozin | 27 | $18,644 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $16,190 |
| OzempicSemaglutide | 15 | $16,036 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 20 | $9,723 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $7,820 |
| Spiriva RespimatTiotropium Bromide | 13 | $7,808 |
| XareltoRivaroxaban | 14 | $7,611 |
| Sucralfate | 32 | $4,140 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $4,113 |
| Olanzapine | 62 | $3,916 |
| Gabapentin | 165 | $3,121 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 80 | $2,912 |
| Memantine Hcl | 32 | $2,839 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $40 | $16,03615 claims |
| Lilly USA, LLCOlanzapine | $38 | $3,91662 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 53 gerontology providers in Oregon.
Other gerontology in Ontario
- Lauren BrownPortland$32K
- Alexia DudoitBend$14K
- Kimberly FlowersPortland$5K
- Jennifer GardnerEugene$5K
- Molly DavisPortland$3K
- Jennifer TurnerPortland$3K
- Timothy HiltonSalem$2K
- Jennifer GoodrichPortland$2K
- Chandler KramerEugene$1K
- Rhezarie Mae AgtarapPortland$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.